Clay Northam Wealth Management’s ROBO Global Healthcare Technology and Innovation ETF HTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$754K Buy
17,000
+1,000
+6% +$40.8K 0.35% 47
2026
Q2
$597K Sell
16,000
-1,500
-9% -$51.4K 0.29% 56
2026
Q1
$578K Buy
17,500
+400
+2% +$14.1K 0.32% 51
2025
Q4
$604K Sell
17,100
-535
-3% -$18.2K 0.34% 48
2025
Q3
$544K Sell
17,635
-180
-1% -$5.33K 0.31% 49
2025
Q2
$508K Sell
17,815
-3,130
-15% -$84.3K 0.32% 49
2025
Q1
$572K Buy
20,945
+400
+2% +$11.8K 0.4% 43
2024
Q4
$593K Sell
20,545
-900
-4% -$26.3K 0.38% 40
2024
Q3
$637K Buy
21,445
+395
+2% +$11.3K 0.44% 34
2024
Q2
$573K Sell
21,050
-465
-2% -$12.7K 0.43% 37
2024
Q1
$612K Buy
21,515
+185
+0.9% +$5.16K 0.49% 33
2023
Q4
$598K Hold
21,330
– – 0.53% 30
2023
Q3
$539K Hold
21,330
– – 0.53% 31
2023
Q2
$642K Buy
21,330
+200
+0.9% +$5.97K 0.61% 25
2023
Q1
$630K Buy
21,130
+25
+0.1% +$752 0.65% 25
2022
Q4
$610K Hold
21,105
– – 0.7% 25
2022
Q3
$571K Hold
21,105
– – 0.71% 27
2022
Q2
$611K Sell
21,105
-5,665
-21% -$175K 0.76% 27
2022
Q1
$975K Buy
26,770
+5,870
+28% +$217K 0.99% 23
2021
Q4
$911K Buy
+20,900
New +$934K 0.86% 26

Other funds holding HTEC

Clay Northam Wealth Management's HTEC Position: Q3 2026 in Review

Clay Northam Wealth Management increased its ROBO Global Healthcare Technology and Innovation ETF (HTEC) stake by 6.3% in Q3 2026, buying an estimated $40.8K and bringing the position to 17,000 shares worth $754K. The position accounts for 0.35% of the portfolio, ranked #47.

Clay Northam Wealth Management first reported a position in HTEC in Q4 2021 and has held it in 20 quarters since. The position peaked at $975K in Q1 2022. 8 funds tracked by Wall St. Rank hold HTEC as of Q3 2026.

  • Clay Northam Wealth Management held 17,000 shares of ROBO Global Healthcare Technology and Innovation ETF worth $754K as of Q3 2026.
  • Clay Northam Wealth Management bought 1,000 ROBO Global Healthcare Technology and Innovation ETF shares in Q3 2026, an estimated $40.8K.
  • ROBO Global Healthcare Technology and Innovation ETF made up 0.35% of Clay Northam Wealth Management's portfolio in Q3 2026, its #47 holding.
  • Clay Northam Wealth Management first reported a position in ROBO Global Healthcare Technology and Innovation ETF in Q4 2021 and has held it in 20 quarters since.
  • Clay Northam Wealth Management's ROBO Global Healthcare Technology and Innovation ETF position peaked at $975K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held ROBO Global Healthcare Technology and Innovation ETF as of Q3 2026.

Based on Clay Northam Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.